Lavacchi, D.; Roviello, G.; Guidolin, A.; Romano, S.; Venturini, J.; Caliman, E.; Vannini, A.; Giommoni, E.; Pellegrini, E.; Brugia, M.;
et al. Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer. Int. J. Mol. Sci. 2023, 24, 5840.
https://doi.org/10.3390/ijms24065840
AMA Style
Lavacchi D, Roviello G, Guidolin A, Romano S, Venturini J, Caliman E, Vannini A, Giommoni E, Pellegrini E, Brugia M,
et al. Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer. International Journal of Molecular Sciences. 2023; 24(6):5840.
https://doi.org/10.3390/ijms24065840
Chicago/Turabian Style
Lavacchi, Daniele, Giandomenico Roviello, Alessia Guidolin, Silvia Romano, Jacopo Venturini, Enrico Caliman, Agnese Vannini, Elisa Giommoni, Elisa Pellegrini, Marco Brugia,
and et al. 2023. "Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer" International Journal of Molecular Sciences 24, no. 6: 5840.
https://doi.org/10.3390/ijms24065840
APA Style
Lavacchi, D., Roviello, G., Guidolin, A., Romano, S., Venturini, J., Caliman, E., Vannini, A., Giommoni, E., Pellegrini, E., Brugia, M., Pillozzi, S., & Antonuzzo, L.
(2023). Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer. International Journal of Molecular Sciences, 24(6), 5840.
https://doi.org/10.3390/ijms24065840